UofL Physicians Conducting Vaccine Trial for Children with Relapsed Tumors at Kosair Children’s Hosp

Today, however, they and their parents are finding hope in a Phase I research study led by Kenneth G. Lucas, M.D., chief of the division of pediatric hematology/oncology and stem cell transplantation at the University of Louisville. Leading a team of his colleagues at Kosair Children’s Hospital and in the UofL Department of Pediatrics, Lucas is making progress in developing a vaccine that one day could possibly prevent recurrence of some childhood cancers.

Recent Posts

UofL Physicians Conducting Vaccine Trial for Children with Relapsed Tumors at Kosair Children’s Hosp

Study: Nearly 20 years on, no adverse impacts for pediatric cancer patients treated with dexrazoxan

Surviving cancer as a child can affect lifelong health

Drug combination highly effective in children with standard-and high-risk APL

Safety concerns raised for neuroblastoma candidate drug

Radiotherapy may explain why childhood cancer survivors often develop metabolic disease

Can testicular tissue restore childhood cancer survivors’ fertility?

Combining drugs ‘may extend lives of children with incurable brain cancer’

$13,800 in hospital parking for Jake's cancer family

Researchers ‘extraordinarily optimistic’ about potential of CAR-T for pediatric brain cancer